Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Telbivudine MeSH Descriptor Data 2025


MeSH Heading
Telbivudine
Tree Number(s)
D03.383.742.680.705.888
D13.570.230.855.888
D13.570.685.705.888
Unique ID
D000077712
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077712
Scope Note
A thymidine derivative and antiviral agent that inhibits DNA synthesis by HEPATITIS B VIRUS and is used for the treatment of CHRONIC HEPATITIS B.
Entry Term(s)
1-(2-Deoxy-beta-L-erythropentafuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione
Telbivudin
Tyzeka
beta-L-2'-Deoxythymidine
Pharm Action
Antiviral Agents
Nucleic Acid Synthesis Inhibitors
Registry Numbers
2OC4HKD3SF
0
CAS Type 1 Name
2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-beta-L-erythro-pentofuranosyl)-5-methyl-
Public MeSH Note
2019; TELBIVUDINE was indexed under THYMIDINE/analogs & derviatives 2014-2018; and under NUCLEOSIDES and PYRIMIDINONES 2004-2013
History Note
2019 (2004)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/04/09
Telbivudine Preferred
Tyzeka Narrower
page delivered in 0.146s